Inventor
Ehab M. Khalil
Inventor
Whitehouse Station, NJ, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes28%
C07DHeterocyclic compounds28%
C07BGeneral methods of organic chemistry5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07CAcyclic or carbocyclic compounds2%
C07HSugars2%
C07KPeptides2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,669,257Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same202010,189,814Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same20199,968,596Antiproliferative compounds and methods of use thereof20189,828,361Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same20179,822,094'Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same'20179,808,451'Antiproliferative compounds and methods of use thereof'20179,499,514'Antiproliferative compounds and methods of use thereof'20169,309,219'Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same'20168,877,780'5-substituted isoindoline compounds'20148,796,275'Anti-malarial compounds'20148,518,972'Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same'20138,173,654'Triazolopyridazine compounds'20128,030,305'Triazolopyridazines as kinase modulators'20117,868,023'Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions'20117,482,376'Conjugated complement cascade inhibitors'20097,385,066'Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions'20087,138,530'Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions'20067,109,354'Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions'20066,369,030'Inhibitors of histone acetyltransferases (HATs) and uses thereof'20025,990,094'Inhibitors of sorotonin N-acetyltransferase'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2002Based in Bronx, NY, US· patent location history
2006–2009Patents assigned to DIMENSIONAL PHARM INC (3)· patent assignee history
2006–2012Based in West Chester, PA, US· patent location history
2008–2012Patents assigned to JANSSEN PHARMACEUTICA NV (4)· patent assignee history
2012–2014Patents assigned to KHALIL EHAB (2)· patent assignee history
2013–2020Patents assigned to CELGENE CORP (10)· patent assignee history
2013–2014Patents assigned to CHEN ROGER SHEN-CHU (2)· patent assignee history
2013–2017Based in Whitehouse Station, NJ, US· patent location history
2018–2020Based in Yorktown, VA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE CORP | 10 | 2013–2020 |
| JANSSEN PHARMACEUTICA NV | 4 | 2008–2012 |
| DIMENSIONAL PHARM INC | 3 | 2006–2009 |
| CHEN ROGER SHEN-CHU | 2 | 2013–2014 |
| KHALIL EHABself | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Whitehouse Station, New Jersey, US | 8 | 2013–2017 |
| West Chester, Pennsylvania, US | 7 | 2006–2012 |
| Yorktown, Virginia, US | 3 | 2018–2020 |
| Bronx, New York, US | 2 | 1999–2002 |